Avon Products, New York, signed an agreement with Swiss pharmaceutical company Roche Holding AG, Basel, to distribute a line of nutritional supplements. Avon's representatives will market the products in 15 countries worldwide starting in 2001. Avon estimates the vitamin line will generate $200 million to $300 million in annual revenue within the next five years. Also, the company's Avon Breast Cancer Crusade announced a $14 million gift to a network of breast cancer groups to fund research and education programs and medical care for breast cancer patients. Avon will fund a campaign of public service announcements around women's health topics. Ads, created in-house, will be sent to stations soon.
Copyright March 2000, Crain Communications Inc.